Kazuhiro Maejima

Molecular Biology · 2011–2016

A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Kazuhiro Maejima trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Hayami

Who trusts Kazuhiro Maejima overall

  1. Ryuji Hamamoto
  2. Yusuke Nakamura

Papers from Kazuhiro Maejima's perspective

Ordered by how strongly the researchers Kazuhiro Maejima trusts endorse each paper. Same corpus, a different order for every researcher.

  1. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
  2. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
  3. Histone demethylation by a family of JmjC domain-containing proteins (Nature)
  4. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. (New England Journal of Medicine)
  5. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  6. Maintaining genome stability at the replication fork (Nature reviews. Molecular cell biology)
  7. Activation of the MCM2-7 Helicase by Association with Cdc45 and GINS proteins
  8. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. (The Lancet)
  9. Polycomb silencers control cell fate, development and cancer (Nature Reviews. Cancer)
  10. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers

Their papers